AbbVie to Present at Cowen and Company 33rd Annual Health Care Conference
NORTH CHICAGO, Ill., Feb. 20, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) will present at the Cowen and Company 33rd Annual Health Care Conference on Wednesday, March 6, 2013. Bill Chase, executive vice president and chief financial officer, will make a formal presentation on the company at 7:40 a.m. Central time.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations Web site at www.abbvieinvestor.com. An archived edition of the presentation will be available later that day.
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. With its 125-year history, the company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.
More by this Source
AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
Jun 17, 2013, 08:15 ET
Largest Global Survey of Rheumatoid Arthritis Patients Shows Opportunity for Increased Collaboration Between Doctors And Patients And Further Education About Disease Progression
Jun 11, 2013, 10:49 ET
AbbVie to Participate in 34th Annual Goldman Sachs Global Healthcare Conference
Jun 05, 2013, 08:15 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.